Roop K. Lakkaraju serves as Executive Vice President and Chief Financial Officer of Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics. Appointed to this role in May 2021, he oversees the company's worldwide financial operations, including accounting, financial planning and analysis, investor relations, tax, treasury, and internal audit functions. Under his leadership, Bio-Rad has focused on strengthening its balance sheet, optimizing capital allocation, and driving sustainable growth amid evolving market dynamics in biotechnology and healthcare. Prior to joining Bio-Rad, Lakkaraju held senior finance positions at leading technology and life sciences firms. At Illumina, Inc., he served as Senior Vice President and Chief Financial Officer of the Core Illumina business from 2019 to 2021, and earlier as Vice President of Finance for GRAIL, Illumina's cancer detection subsidiary. He spent over a decade at Western Digital Corporation, rising to Vice President of Finance for the Flash Business Unit, where he played a key role in financial strategy during the company's expansion into NAND flash memory. His earlier career included finance roles at Applied Materials, Inc., honing his expertise in high-tech manufacturing and global operations. Lakkaraju's achievements include guiding Illumina through complex financing for GRAIL's spin-off and supporting Western Digital's multi-billion-dollar acquisitions and mergers. A proven leader in scaling businesses, he holds a B.S. in Electrical Engineering from the University of Maryland and an MBA from Santa Clara University's Leavey School of Business. His strategic acumen continues to position Bio-Rad for innovation and long-term shareholder value in the rapidly advancing diagnostics and life sciences sectors.